These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
84. Letter by Brewster and van Montfrans regarding article, "Risks associated with statin therapy: a systematic overview of randomized clinical trials". Brewster LM; van Montfrans GA Circulation; 2007 Jul; 116(1):e7; author reply e9. PubMed ID: 17606851 [No Abstract] [Full Text] [Related]
85. Current world literature. Curr Opin Lipidol; 2011 Dec; 22(6):497-500. PubMed ID: 22101559 [No Abstract] [Full Text] [Related]
94. [Unexpected consequences of an expected adverse effect of cerivastatine]. Imbs JL Rev Med Interne; 2002 Jan; 23(1):1-3. PubMed ID: 11859689 [No Abstract] [Full Text] [Related]
95. [What to do in a patient intolerant to statins?]. Béliard-Lasserre S Rev Prat; 2015 May; 65(5):600-1. PubMed ID: 26165087 [No Abstract] [Full Text] [Related]
96. Drug-drug interactions and statin therapy. Trifiro G South Med J; 2006 Dec; 99(12):1325-6. PubMed ID: 17233186 [No Abstract] [Full Text] [Related]
97. Succinylcholine should be avoided in patients on statin therapy. Lee C Anesthesiology; 2011 Jul; 115(1):6-7. PubMed ID: 21587061 [No Abstract] [Full Text] [Related]
98. Niacin + a statin does not add up to benefit. Harv Health Lett; 2012 Feb; 37(4):7. PubMed ID: 27024379 [No Abstract] [Full Text] [Related]
99. Statins for primary prevention of coronary artery disease. Mascitelli L; Pezzetta F Lancet; 2007 Mar; 369(9567):1078-9; author reply 1079. PubMed ID: 17398298 [No Abstract] [Full Text] [Related]